Active Biotech AB (publ) (STO:ACTI)
3.360
-0.145 (-4.14%)
Nov 20, 2026, 5:29 PM CET
Active Biotech AB Market Cap
Active Biotech AB has a market cap or net worth of 88.57 million as of November 20, 2026. It is the 41,865th most valuable company in the world and the 618th biggest in Sweden. Its market cap has decreased by 11.76% in one year.
Market Cap
88.57M
Enterprise Value
52.27M
Revenue
n/a
Global Rank
Country Rank
#618 Sweden
PE Ratio
n/a
ChartMarket Cap Chart
Since March 11, 1998, Active Biotech AB's market cap has increased from 6.93M to 88.57M, an increase of 1,178.02%. That is a compound annual growth rate of 9.28%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2026 | 88.57M | -26.96% |
| Dec 30, 2025 | 121.26M | 4.60% |
| Dec 30, 2024 | 115.93M | -29.80% |
| Dec 29, 2023 | 165.13M | -35.20% |
| Dec 30, 2022 | 254.82M | -7.51% |
| Dec 30, 2021 | 275.52M | 0.37% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| BioInvent International AB | 137.53M |
| Simris Group AB (PUBL) | 137.49M |
| Xintela AB | 121.44M |
| IRLAB Therapeutics AB | 108.41M |
| Alzinova AB | 97.82M |
| Biovica International AB | 87.57M |
| OncoZenge AB | 78.80M |
| Annexin Pharmaceuticals AB | 77.59M |